Viatris Cash Flow Statement
NASDAQ: VTRSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Viatris free cash flow
In fiscal 2025, Viatris generated $2.32 billion of operating cash flow and spent $378.8 million on capital expenditures. That left free cash flow of $1.94 billion, a free-cash-flow margin of 13.5% of revenue. Free cash flow was down 2.0% from the prior year's $1.98 billion.
Viatris returned $500.5 million to shareholders through share repurchases, equal to 26% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
Viatris cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -3.51B | -634.20M | 54.70M | 2.08B | -1.27B | -669.90M | 16.80M | 352.50M |
| Net Income growth (YoY) | — | -1259.41% | -97.37% | — | — | -4087.50% | -95.23% | — |
| Depreciation & Amortization | 2.80B | 2.89B | 2.74B | 3.03B | 4.51B | 2.22B | 2.02B | 2.11B |
| Stock-Based Compensation | 177.70M | 146.10M | 180.70M | 116.40M | 111.20M | 79.20M | 56.80M | -3.30M |
| Change in Working Capital | 60.20M | -387.30M | -220.00M | -329.60M | -438.70M | -745.90M | -629.20M | 12.80M |
| Operating Cash Flow | 2.32B | 2.30B | 2.90B | 3.00B | 3.02B | 1.23B | 1.80B | 2.34B |
| Capital Expenditures | -378.80M | -326.00M | -377.00M | -406.00M | -457.20M | -243.00M | -213.20M | -252.10M |
| Investing Cash Flow | -427.70M | 1.80B | -864.50M | 1.47B | -117.80M | -301.10M | -525.40M | -1.21B |
| Share Repurchases | -500.50M | -250.00M | -250.00M | 0 | 0 | 0 | 0 | -432.00M |
| Debt Issued | 0 | 0 | 300.00K | 1.88B | 1.71B | 983.30M | 7.40M | 2.58B |
| Debt Repaid | -100.00K | -3.71B | -1.25B | -3.66B | -4.20B | -2.48B | -1.11B | -3.17B |
| Financing Cash Flow | -1.29B | -4.33B | -2.30B | -3.88B | -3.01B | -605.70M | -1.17B | -1.09B |
| Net Change in Cash | 611.90M | -257.50M | -268.90M | 556.30M | -143.80M | 358.80M | 101.80M | 19.40M |
| Free Cash Flow | 1.94B | 1.98B | 2.52B | 2.59B | 2.56B | 988.80M | 1.59B | 2.09B |
This table shows 8 annual periods of Viatris's cash flow statement, from FY 2025 back to FY 2018, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow VTRS's reporting calendar. What is a cash flow statement?